Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology

被引:250
|
作者
Tsao, Connie W. [1 ,2 ,3 ]
Vasan, Ramachandran S. [1 ,4 ,5 ]
机构
[1] Framingham Heart Dis Epidemiol Study, Framingham, MA USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Boston Univ, Sch Med, Sect Cardiol & Preventat Med, Boston, MA 02118 USA
[5] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
基金
美国国家卫生研究院;
关键词
GENOME-WIDE ASSOCIATION; INDEPENDENT RISK-FACTOR; LEFT-VENTRICULAR MASS; CHRONIC ATRIAL-FIBRILLATION; SEQUENCING IDENTIFIES RARE; HIGH-DENSITY-LIPOPROTEIN; FLOW-MEDIATED DILATION; ANKLE-BRACHIAL INDEX; BLOOD-PRESSURE; LONG-TERM;
D O I
10.1093/ije/dyv337
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The Framingham Heart Study (FHS) has conducted seminal research defining cardiovascular disease (CVD) risk factors and fundamentally shaping public health guidelines for CVD prevention over the past five decades. The success of the Original Cohort, initiated in 1948, paved the way for further epidemiological research in preventive cardiology. Due to the keen observations suggesting the role of shared familial factors in the development of CVD, in 1971 the FHS began enroling the second generation cohort, comprising the children of the Original Cohort and the spouses of the children. In 2002, the third generation cohort, comprising the grandchildren of the Original Cohort, was initiated to additionally explore genetic contributions to CVD in greater depth. Additionally, because of the predominance of White individuals of European descent in the three generations of FHS participants noted above, the Heart Study enrolled the OMNI1 and OMNI2 cohorts in 1994 and 2003, respectively, aimed to reflect the current greater racial and ethnic diversity of the town of Framingham. All FHS cohorts have been examined approximately every 2-4 years since the initiation of the study. At these periodic Heart Study examinations, we obtain a medical history and perform a cardiovascular-focused physical examination, 12-lead electrocardiography, blood and urine samples testing and other cardiovascular imaging studies reflecting subclinical disease burden. The FHS has continually evolved along the cutting edge of cardiovascular science and epidemiological research since its inception. Participant studies now additionally include study of cardiovascular imaging, serum and urine biomarkers, genetics/genomics, proteomics, metabolomics and social networks. Numerous ancillary studies have been established, expanding the phenotypes to encompass multiple organ systems including the lungs, brain, bone and fat depots, among others. Whereas the FHS was originally conceived and designed to study the epidemiology of cardiovascular disease, it has evolved over the years with staggering expanded breadth and depth that have far greater implications in the study of the epidemiology of a wide spectrum of human diseases. The FHS welcomes research collaborations using existing or new collection of data. Detailed information regarding the procedures for research application submission and review are available at [http://www.framinghamheartstudy.org/researchers/index.php].
引用
收藏
页码:1800 / 1813
页数:14
相关论文
共 50 条
  • [31] EPIDEMIOLOGY OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY
    CASTELLI, WP
    AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A): : 4 - 12
  • [32] Epidemiology of cardiovascular disease in Japan: An overview study
    Ohira, Tetsuya
    Eguchi, Eri
    Hayashi, Fumikazu
    Kinuta, Minako
    Imano, Hironori
    JOURNAL OF CARDIOLOGY, 2024, 83 (03) : 191 - 200
  • [33] Reference values for left atrial size by cardiovascular magnetic resonance in the Framingham Heart Study Offspring cohort
    Garima Arora
    Philimon Gona
    Carol J Salton
    Susan J Blease
    Christopher J O'Donnell
    Warren J Manning
    Michael L Chuang
    Journal of Cardiovascular Magnetic Resonance, 14 (Suppl 1)
  • [34] Lacunar Infarcts and Intracerebral Hemorrhage Differences: A Nested Case-Control Analysis in the FHS (Framingham Heart Study)
    Lioutas, Vasileios-Arsenios
    Beiser, Alexa
    Himali, Jayandra
    Aparicio, Hugo
    Romero, Jose Rafael
    DeCarli, Charles
    Seshadri, Sudha
    STROKE, 2017, 48 (02) : 486 - 489
  • [35] Normal Right Ventricle Anatomy and Function in a Longitudinally Followed Cohort Free of Hypertension and Cardiovascular Disease: A Cardiovascular Magnetic Resonance Study of the Framingham Heart Study Offspring Cohort
    Arora, Garima
    Gona, Philmon
    Salton, Carol J.
    Chuang, Michael L.
    Jhaveri, Rahul R.
    Velagaleti, Raghava S.
    Yeon, Susan B.
    O'Donnell, Christopher J.
    Manning, Warren J.
    CIRCULATION, 2009, 120 (18) : S546 - S546
  • [36] Serum potassium and risk of cardiovascular disease - The Framingham Heart Study
    Walsh, CR
    Larson, MG
    Leip, ER
    Vasan, RS
    Levy, D
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (09) : 1007 - 1012
  • [37] Intermittent claudication - A risk profile from the Framingham Heart Study
    Murabito, JM
    DAgostino, RB
    Silbershatz, H
    Wilson, PWF
    CIRCULATION, 1997, 96 (01) : 44 - 49
  • [38] HEART-RATE AND CARDIOVASCULAR MORTALITY IN THE FRAMINGHAM-STUDY
    KANNEL, WB
    KANNEL, CE
    PAFFENBARGER, R
    CIRCULATION, 1985, 72 (04) : 151 - 151
  • [39] Impaired fasting glucose and cardiovascular disease: The Framingham heart study
    Levitzky, Yamini S.
    Pencina, Michael J.
    D'Agostino, Ralph B.
    Meigs, James B.
    Murabito, Joanne M.
    Vasan, Ramachandran S.
    Fox, Caroline S.
    DIABETES, 2006, 55 : A1 - A1
  • [40] Cardiovascular correlates of platelet count and volume in the Framingham Heart Study
    Sloan, Arielle
    Gona, Philimon
    Johnson, Andrew D.
    ANNALS OF EPIDEMIOLOGY, 2015, 25 (07) : 492 - 498